Professor Shuajp Kraja is the first Albanian inventor who owns the European patent for the vaccine against cancer. Regarded as an innovative inventions in the field of medicine, the issuance of this patent by the European Patent Organization (EPO), paves the way for the authorization of procedures of the production of this vaccine by the European Union.
In the framework of the pilot study with volunteers patients, with the anticancer vaccine Bi are treated and cured for a long time many peoples. This special vaccine has proved the complete treatment of various forms of cancers.
Bi vaccine constitutes a commod treatment and is expected ti replace the "artillery" of heavy chemotherapy and radiotherapy, will be able to recognize and selectively destroy malignant cells without damaging healthy cells of the body.Bi vaccine is applied to treat various forms of cancer and also applies in immunization against cancer occurrence in healthy people, but likely to develop cancer. The patent for this invention is known in many countries and international institutions like the European Office, Germany, Switzerland, France, UK, Ireland, Albania, Kosovo and Croatia.
Professor Kraja has also received a second patent for the drug "Shukrain 55" at the European level, and this is registered for a patent at the institution of the Patent and Trademark Registration, this time in Germany.
The drug has a wide spectrum and is also proven effective against pathogenic viruses that are dangerous to human health as HIV AIDS and viral hepatitis, preventing its outbreak.
Prof. Shuajp Kraja was born in the city of Shkodra in 1936. He specialized in molecular biology. Kraja has a rich career of academic science, exceeding the Albanian borders.